Families often ask whether neurofeedback can replace ADHD medication. The evidence does not support treating this as a simple either-or decision. Medication has a stronger established evidence base, while neurofeedback has a substantial but more debated literature.
Stimulant and non-stimulant medications are established ADHD treatments and are included in major clinical guidelines. They can reduce core symptoms for many patients, although response, side effects and preferences differ from person to person.
ADHD is one of the most researched neurofeedback applications. Some trials and meta-analyses report improvements in attention and behaviour, while blinded analyses and guideline reviews are more cautious. Protocol, comparator, expectancy effects and study design all influence the conclusions.
For some patients, neurofeedback may be considered as an adjunct to established care rather than a replacement. Treatment decisions can include medication, behavioural strategies, psychotherapy, parent support, school accommodations, sleep interventions and neurofeedback depending on the individual presentation.
A good plan starts with the person rather than the technology. Attention, impulsivity, executive function, emotional regulation, sleep, anxiety, learning concerns and medication tolerance may all shape the discussion. Progress should be measured in daily functioning, not just training-session data.